Benzothiazole-Derived Compounds as Potential Drugs for the Treatment of Type 2 Diabetes: A Descriptive Review
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27198863 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ana María Correa-Basurto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biofísica y Biocatálisis, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Naciona…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Benzothiazoles. Die Arbeit nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional, Secretaría de Investigación y Posgrado of Instituto Politécnico Nacional.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes (T2D) is a multifactorial metabolic disease in which hyperglycemia coexists with insulin resistance, β-cell dysfunction, dyslipidemia, and progressive microvascular and macrovascular complications. The structural versatility of the benzothiazole scaffold has enabled the development of a diverse array of preclinical compounds capable of modulating multiple diabetes-relevant targets. This review critically analyzes the available evidence on benzothiazole-derived compounds exhibiting antidiabetic or other diabetes-related pharmacological activities. No lower publication-date limit was imposed, and the literature included in the review ranged from 1997 to March 2026, encompassing in silico, in vitro, ex vivo, and in vivo evidence. The compounds are discussed according to their primary molecular targets, including α-glucosidase and α-amylase, dipeptidyl peptidase-4 (DPP-4), peroxisome proliferator-activated receptor -γ (PPAR-γ), protein tyrosine phosphatase 1B (PTP1B), glycogen phosphorylase, 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1), aldose reductase, AMPK, and other emerging metabolic targets. Structure–activity relationships (SAR) are highlighted, demonstrating that C-2 functionalization, substitution at the C-5 and C-6 positions, halogenation, the presence of electron-donating or electron-withdrawing groups, and hybridization with thiazolidinedione, rhodanine, triazole, oxadiazole, and other pharmacophores can markedly alter potency, selectivity, and metabolic effects. Various derivatives have matched or outperformed reference agents such as acarbose, glibenclamide, pioglitazone, or aldose reductase inhibitors in preclinical assays. However, a direct comparison between studies is limited by the heterogeneity of models, endpoints, units, and dosing regimens, and clinical efficacy for T2D has not yet been established for this chemical class. Overall, the benzothiazole scaffold emerges not as a universal antidiabetic pharmacophore, but as a highly adaptable platform for the rational design of multitarget compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Biofísica y Biocatálisis, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Salvador Díaz Mirón s/n, Casco de Santo Tomás, M…
- Unidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades 2 Piso CORSE Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Av. Cuauhtémoc 330, Col. Doctores, Ciudad de México 06…
- Laboratorio de Inmunología, Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana Unidad Xochimilco, Calz. del Hueso 1100, Coapa, Villa Quietud, Coyoacán, Ciudad de México 04960, Mexico.
- Laboratorio de Química Supramolecular y Nanociencias, Unidad Profesional Interdisciplinaria de Biotecnología, Instituto Politécnico Nacional, Av. Acueducto s/n, Barrio La Laguna Ticomán, Ciudad de México 07340, Mexico.
- Licenciatura de Química Farmacéutico Biológica, Área Farmacéutica, Facultad de Estudios Superiores (FES)-Zaragoza, Universidad Nacional Autónoma de México (UNAM), Batalla 5 de mayo s/n, Ejército de Oriente, Iztapalapa,…
- Academia de Farmacología y Toxicología, Licenciatura de Química Farmacéutico Biológica, Facultad de Estudios Superiores (FES)-Zaragoza, Universidad Nacional Autónoma de México (UNAM), Batalla 5 de mayo s/n, Ejército de…
ORCID-Profile: Miguel Valdes, Natalia Reyes Vallejo, Alejandro Cruz, Martha Cecilia Rosales-Hernández, Juan Andres Alvarado-Salazar, Jessica Elena Mendieta-Wejebe
Förderung
- Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional
- Secretaría de Investigación y Posgrado of Instituto Politécnico Nacional
Zitieren
APA
Correa-Basurto, A. M., Valdes, M., Cabrera-Pérez, L. C., Vallejo, N. R., Cruz, A., Rosales-Hernández, M. C., Alvarado-Salazar, J. A., & Mendieta-Wejebe, J. E. (2026). Benzothiazole-Derived Compounds as Potential Drugs for the Treatment of Type 2 Diabetes: A Descriptive Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198863
Vancouver
Correa-Basurto AM, Valdes M, Cabrera-Pérez LC, Vallejo NR, Cruz A, Rosales-Hernández MC, et al. Benzothiazole-Derived Compounds as Potential Drugs for the Treatment of Type 2 Diabetes: A Descriptive Review. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198863
BibTeX
@article{CorreaBasurto2026,
author = {Correa-Basurto, Ana María and Valdes, Miguel and Cabrera-Pérez, Laura Cristina and Vallejo, Natalia Reyes and Cruz, Alejandro and Rosales-Hernández, Martha Cecilia and Alvarado-Salazar, Juan Andres and Mendieta-Wejebe, Jessica Elena},
title = {Benzothiazole-Derived Compounds as Potential Drugs for the Treatment of Type 2 Diabetes: A Descriptive Review},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27198863}
}
EUVIMED